167 related articles for article (PubMed ID: 27014363)
21. Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening?
Kanber Y; Charbonneau M; Auger M
Cancer Cytopathol; 2015 Dec; 123(12):739-44. PubMed ID: 26348845
[TBL] [Abstract][Full Text] [Related]
22. Challenges in the Pap diagnosis of endocervical adenocarcinoma in situ.
Niu S; Molberg K; Thibodeaux J; Rivera-Colon G; Hinson S; Zheng W; Lucas E
J Am Soc Cytopathol; 2019; 8(3):141-148. PubMed ID: 31097290
[TBL] [Abstract][Full Text] [Related]
23. Comparison of papanicolaou smear and human papillomavirus (HPV) test as cervical screening tools: can we rely on HPV test alone as a screening method? An 11-year retrospective experience at a single institution.
Kang M; Ha SY; Cho HY; Chung DH; Kim NR; An J; Lee S; Seok JY; Jeong J
J Pathol Transl Med; 2020 Jan; 54(1):112-118. PubMed ID: 31964113
[TBL] [Abstract][Full Text] [Related]
24. The Efficiency of Cervical Pap and Comparison of Conventional Pap Smear and Liquid-Based Cytology: A Review.
Dasgupta S
Cureus; 2023 Nov; 15(11):e48343. PubMed ID: 38060751
[TBL] [Abstract][Full Text] [Related]
25. Obstacles to the early detection of endocervical adenocarcinoma.
Kalir T; Simsir A; Demopoulos HB; Demopoulos RI
Int J Gynecol Pathol; 2005 Oct; 24(4):399-403. PubMed ID: 16175089
[TBL] [Abstract][Full Text] [Related]
26. Glandular cell atypia on Papanicolaou smears: interobserver variability in the diagnosis and prediction of cell of origin.
Simsir A; Hwang S; Cangiarella J; Elgert P; Levine P; Sheffield MV; Roberson J; Talley L; Chhieng DC
Cancer; 2003 Dec; 99(6):323-30. PubMed ID: 14681938
[TBL] [Abstract][Full Text] [Related]
27. Interpretation of Endocervical Cells With Gastric-Type Mucin on Pap Smears.
Omori M; Kondo T; Nakazawa K; Tagaya H; Ohgi M; Fukasawa H; Nakazawa T; Hashi A; Hirata S
Am J Clin Pathol; 2018 Jul; 150(3):259-266. PubMed ID: 29982289
[TBL] [Abstract][Full Text] [Related]
28. Value of histiocyte detection in Pap smears for predicting endometrial pathology. An institutional experience.
Nassar A; Fleisher SR; Nasuti JF
Acta Cytol; 2003; 47(5):762-7. PubMed ID: 14526675
[TBL] [Abstract][Full Text] [Related]
29. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
Liao SY; Stanbridge EJ
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
[TBL] [Abstract][Full Text] [Related]
30. ThinPrep Pap Test promotes detection of glandular lesions of the endocervix.
Bai H; Sung CJ; Steinhoff MM
Diagn Cytopathol; 2000 Jul; 23(1):19-22. PubMed ID: 10907926
[TBL] [Abstract][Full Text] [Related]
31. Performance and cost analysis of Siriraj liquid-based cytology: a direct-to-vial study.
Laiwejpithaya S; Benjapibal M; Laiwejpithaya S; Wongtiraporn W; Sangkarat S; Rattanachaiyanont M
Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):201-5. PubMed ID: 19747757
[TBL] [Abstract][Full Text] [Related]
32. Comparative evaluation of conventional cytology and a low-cost liquid-based cytology technique, EziPREP™, for cervicovaginal smear reporting: A split sample study.
Gupta R; Yadav R; Sharda A; Kumar D; Sandeep ; Mehrotra R; Gupta S
Cytojournal; 2019; 16():22. PubMed ID: 31803248
[TBL] [Abstract][Full Text] [Related]
33. Cervical cancer screening by molecular Pap-transformation of gynecologic cytology.
Barodawala SM; Chadha K; Kavishwar V; Murthy A; Shetye S
Diagn Cytopathol; 2019 May; 47(5):374-381. PubMed ID: 30468313
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of abnormal pap smears in the western region of Saudi Arabia from 2010 to 2022.
Andijany AA; Abdulhafeez DA; Fadag RB; Al Harbi AM; Alsahafi RA; Bin Abbas ES; Felemban WA
Cytojournal; 2023; 20():44. PubMed ID: 38053634
[TBL] [Abstract][Full Text] [Related]
35. ThinPrep detection of cervical and endometrial adenocarcinoma: a retrospective cohort study.
Schorge JO; Hossein Saboorian M; Hynan L; Ashfaq R
Cancer; 2002 Dec; 96(6):338-43. PubMed ID: 12478681
[TBL] [Abstract][Full Text] [Related]
36. The Diagnostic Value of Routine Papanicolaou Smears for Detecting Endometrial Cancers: An Update.
Lai CR; Hsu CY; Hang JF; Li AF
Acta Cytol; 2015; 59(4):315-8. PubMed ID: 26315394
[TBL] [Abstract][Full Text] [Related]
37. Glandular Cell Abnormalities on SurePath Preparations: A Retrospective Review with Cytology-Histology Correlations.
Fischer G; Cormier K
Acta Cytol; 2018; 62(5-6):423-429. PubMed ID: 30244241
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological significance of atypical glandular cells on cervicovaginal Pap smears.
Kim MK; Lee YK; Hong SR; Lim KT
Diagn Cytopathol; 2017 Oct; 45(10):867-872. PubMed ID: 28771986
[TBL] [Abstract][Full Text] [Related]
39. Severe cervical glandular cell lesions and severe cervical combined lesions: predictive value of the papanicolaou smear.
van Aspert-van Erp AJ; Smedts FM; Vooijs GP
Cancer; 2004 Aug; 102(4):210-7. PubMed ID: 15368312
[TBL] [Abstract][Full Text] [Related]
40. Predictive value of diagnoses of endocervical glandular abnormalities in cervical smears.
Segal A; Frost FA; Miranda A; Fletcher C; Sterrett GF
Pathology; 2003 Jun; 35(3):198-203. PubMed ID: 14506961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
